A new commercial for AstraZeneca’s Truqap constructs a vision of the extra time that the AKT inhibitor can unlock for some breast cancer patients. More: AstraZeneca unfolds first DTC TV ad for breast cancer med Truqap Source: fierce
read more
New therapy offers hope for patients with limited option More: Lynozyfic receives EU approval for relapsed multiple myeloma treatment Source: News
read more
Study paves the way for personalised therapies for osteoarthritis sufferer More: Hundreds of genetic links to osteoarthritis unlocked Source: News
read moreSix months after entering talks with U.S. private equity firm Clayton, Dubilier & Rice, Sanofi has closed a deal to sell a 50% controlling stake of its consumer health business Opella for 10 billion euros ($11.4 billion). More: Sanofi nets
read moreGSK says it has identified “mitigation options” to navigate potential U.S. pharmaceutical tariffs. More: As vaccine sales slip, GSK touts 'mitigation options' for potential drug tariffs Source: fierce
read moreThe FDA on Wednesday approved J&J’s nipocalimab under the brand name Imaavy as a new treatment for generalized myasthenia gravis. The green light will likely tee off a showdown between J&J and established myasthenia gravis players Argenx and UCB. More:
read more© 1994 - 2025 B.M. Pharmaceuticals